A new survey report from Tufts Centre for the Study of Drug Development has highlighted that life sciences companies plan to use a greater range of patient data in clinical trials for more accurate decision-making.
Survey
The second report from the 2017 eClinical Landscape Study, revealed that 97% of companies (that participated in the survey) will increase the use of at least one clinical data source to make faster, more accurate decisions during trials. However, the results of the survey also demonstrated that 98% currently experience challenges with their clinical data management systems.